Ekonomik Sonuçlar

Restrictive blood transfusion practices are associated with improved patient outcomes. (yeni pencere açar)

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, Shah N.

Kaynak‎: Transfusion 2014;54(10 Pt 2):2753-9.

İndeks‎: PubMed 24995770

DOI‎: 10.1111/trf.12723

https://www.ncbi.nlm.nih.gov/pubmed/24995770 (yeni pencere açar)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (yeni pencere açar)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Kaynak‎: Transfusion 2017;57(6):1347-58.

İndeks‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (yeni pencere açar)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (yeni pencere açar)

MacLaren R, Sullivan PW.

Kaynak‎: Value Health 2005;8(2):105-16.

İndeks‎: PubMed 15804319

DOI‎: 10.1111/j.1524-4733.2005.04006.x

https://www.ncbi.nlm.nih.gov/pubmed/15804319 (yeni pencere açar)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (yeni pencere açar)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Kaynak‎: Transfusion 2015;55(12):2807-15.

İndeks‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (yeni pencere açar)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (yeni pencere açar)

Nardi G, Agostini V, Rondinelli B, Russo E, Bastianini B, Bini G, Bulgarelli S, Cingolani E, Donato A, Gambale G, Ranaldi G

Kaynak‎: Crit Care 2015;19:83.

İndeks‎: PubMed 25880548

DOI‎: 10.1186/s13054-015-0817-9

https://www.ncbi.nlm.nih.gov/pubmed/25880548 (yeni pencere açar)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (yeni pencere açar)

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C.

Kaynak‎: Health Technol Assess 2013;17(10):1-79.

İndeks‎: PubMed 23477634

DOI‎: 10.3310/hta17100

https://www.ncbi.nlm.nih.gov/pubmed/23477634 (yeni pencere açar)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (yeni pencere açar)

Stein DM, Dutton RP, Kramer ME, Scalea TM.

Kaynak‎: J Trauma 2009;66(1):63-72.

İndeks‎: PubMed 19131807

DOI‎: 10.1097/TA.0b013e318191bc8a

https://www.ncbi.nlm.nih.gov/pubmed/19131807 (yeni pencere açar)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (yeni pencere açar)

Zilberberg MD, Shorr AF.

Kaynak‎: BMC Health Serv Res 2007;7:138.

İndeks‎: PubMed 17764560

DOI‎: 10.1186/1472-6963-7-138

https://www.ncbi.nlm.nih.gov/pubmed/17764560 (yeni pencere açar)

YOĞUN BAKIM

Ekonomik Sonuçlar

Türkçe

Ekonomik Sonuçlar

https://assetsnffrgf-a.akamaihd.net/assets/ct/5a91b826b0/images/syn_placeholder_sqr.png

Restrictive blood transfusion practices are associated with improved patient outcomes. (yeni pencere açar)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (yeni pencere açar)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (yeni pencere açar)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (yeni pencere açar)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (yeni pencere açar)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (yeni pencere açar)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (yeni pencere açar)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (yeni pencere açar)

Hastane İrtibat Heyeti Yerel Temsilcisiyle İletişime Geçin

Tıbbi Bilgilendirme Paketleri

Videolar

Ekonomik Sonuçlar

Dilinizi Seçin

Paylaş